BILIBILI INC-SPONSORED ADR (BILI) Fundamental Analysis & Valuation

NASDAQ:BILI • US0900401060

Current stock price

25.62 USD
+0.42 (+1.67%)
At close:
25.66 USD
+0.04 (+0.16%)
After Hours:

This BILI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. BILI Profitability Analysis

1.1 Basic Checks

  • BILI had positive earnings in the past year.
  • BILI had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: BILI reported negative operating cash flow in multiple years.
BILI Yearly Net Income VS EBIT VS OCF VS FCFBILI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B -4B 6B -6B

1.2 Ratios

  • BILI has a Return On Assets of 2.90%. This is in the better half of the industry: BILI outperforms 65.22% of its industry peers.
  • BILI has a Return On Equity of 7.66%. This is in the better half of the industry: BILI outperforms 76.81% of its industry peers.
  • BILI's Return On Invested Capital of 3.46% is fine compared to the rest of the industry. BILI outperforms 60.87% of its industry peers.
Industry RankSector Rank
ROA 2.9%
ROE 7.66%
ROIC 3.46%
ROA(3y)-5.25%
ROA(5y)-9.35%
ROE(3y)-11.8%
ROE(5y)-23.17%
ROIC(3y)N/A
ROIC(5y)N/A
BILI Yearly ROA, ROE, ROICBILI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60

1.3 Margins

  • Looking at the Profit Margin, with a value of 3.93%, BILI is in the better half of the industry, outperforming 63.77% of the companies in the same industry.
  • BILI has a Operating Margin of 3.71%. This is comparable to the rest of the industry: BILI outperforms 59.42% of its industry peers.
  • The Gross Margin of BILI (36.62%) is worse than 73.91% of its industry peers.
  • In the last couple of years the Gross Margin of BILI has grown nicely.
Industry RankSector Rank
OM 3.71%
PM (TTM) 3.93%
GM 36.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y27.72%
GM growth 5Y9.12%
BILI Yearly Profit, Operating, Gross MarginsBILI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. BILI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BILI is destroying value.
  • Compared to 1 year ago, BILI has less shares outstanding
  • The number of shares outstanding for BILI has been increased compared to 5 years ago.
  • The debt/assets ratio for BILI is higher compared to a year ago.
BILI Yearly Shares OutstandingBILI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
BILI Yearly Total Debt VS Total AssetsBILI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.2 Solvency

  • BILI has a Debt/Equity ratio of 0.62. This is a neutral value indicating BILI is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.62, BILI is not doing good in the industry: 68.12% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.67
WACC5.17%
BILI Yearly LT Debt VS Equity VS FCFBILI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B 15B 20B

2.3 Liquidity

  • BILI has a Current Ratio of 1.36. This is a normal value and indicates that BILI is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of BILI (1.36) is worse than 63.77% of its industry peers.
  • BILI has a Quick Ratio of 1.36. This is a normal value and indicates that BILI is financially healthy and should not expect problems in meeting its short term obligations.
  • BILI has a worse Quick ratio (1.36) than 63.77% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.36
BILI Yearly Current Assets VS Current LiabilitesBILI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. BILI Growth Analysis

3.1 Past

  • BILI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8628.57%, which is quite impressive.
  • The Revenue has grown by 13.10% in the past year. This is quite good.
  • The Revenue has been growing by 20.39% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)8628.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.31%
Revenue 1Y (TTM)13.1%
Revenue growth 3Y11.49%
Revenue growth 5Y20.39%
Sales Q2Q%7.59%

3.2 Future

  • Based on estimates for the next years, BILI will show a very strong growth in Earnings Per Share. The EPS will grow by 31.33% on average per year.
  • The Revenue is expected to grow by 9.55% on average over the next years. This is quite good.
EPS Next Y35.73%
EPS Next 2Y34.95%
EPS Next 3Y30.65%
EPS Next 5Y31.33%
Revenue Next Year9.45%
Revenue Next 2Y9.19%
Revenue Next 3Y10.61%
Revenue Next 5Y9.55%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BILI Yearly Revenue VS EstimatesBILI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B 50B
BILI Yearly EPS VS EstimatesBILI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 10 -10 20 30

More info and screens

Find the best growth stocksShow best growing peers

3

4. BILI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 29.45, BILI can be considered very expensive at the moment.
  • BILI's Price/Earnings ratio is in line with the industry average.
  • BILI's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.71.
  • The Price/Forward Earnings ratio is 21.81, which indicates a rather expensive current valuation of BILI.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BILI is on the same level as its industry peers.
  • When comparing the Price/Forward Earnings ratio of BILI to the average of the S&P500 Index (23.83), we can say BILI is valued inline with the index average.
Industry RankSector Rank
PE 29.45
Fwd PE 21.81
BILI Price Earnings VS Forward Price EarningsBILI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BILI Per share dataBILI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • BILI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BILI's earnings are expected to grow with 30.65% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.82
PEG (5Y)N/A
EPS Next 2Y34.95%
EPS Next 3Y30.65%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BILI Dividend Analysis

5.1 Amount

  • BILI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BILI Fundamentals: All Metrics, Ratios and Statistics

BILIBILI INC-SPONSORED ADR

NASDAQ:BILI (3/16/2026, 4:10:07 PM)

After market: 25.66 +0.04 (+0.16%)

25.62

+0.42 (+1.67%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)03-05
Earnings (Next)05-11
Inst Owners9.25%
Inst Owner Change-5.41%
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap10.44B
Revenue(TTM)30.35B
Net Income(TTM)1.19B
Analysts82.78
Price Target30.84 (20.37%)
Short Float %4.26%
Short Ratio5.85
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.39%
Min EPS beat(2)5.62%
Max EPS beat(2)23.15%
EPS beat(4)4
Avg EPS beat(4)18.95%
Min EPS beat(4)5.62%
Max EPS beat(4)41.24%
EPS beat(8)7
Avg EPS beat(8)13.18%
EPS beat(12)10
Avg EPS beat(12)11.3%
EPS beat(16)13
Avg EPS beat(16)8.72%
Revenue beat(2)1
Avg Revenue beat(2)-0.63%
Min Revenue beat(2)-1.56%
Max Revenue beat(2)0.31%
Revenue beat(4)1
Avg Revenue beat(4)-0.95%
Min Revenue beat(4)-1.82%
Max Revenue beat(4)0.31%
Revenue beat(8)2
Avg Revenue beat(8)-0.9%
Revenue beat(12)2
Avg Revenue beat(12)-1.3%
Revenue beat(16)2
Avg Revenue beat(16)-1.4%
PT rev (1m)0%
PT rev (3m)1.06%
EPS NQ rev (1m)-5.33%
EPS NQ rev (3m)-8.17%
EPS NY rev (1m)0%
EPS NY rev (3m)0.36%
Revenue NQ rev (1m)2.11%
Revenue NQ rev (3m)2.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.03%
Valuation
Industry RankSector Rank
PE 29.45
Fwd PE 21.81
P/S 2.37
P/FCF N/A
P/OCF N/A
P/B 4.62
P/tB 7.47
EV/EBITDA N/A
EPS(TTM)0.87
EY3.4%
EPS(NY)1.17
Fwd EY4.59%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS10.8
BVpS5.54
TBVpS3.43
PEG (NY)0.82
PEG (5Y)N/A
Graham Number10.41
Profitability
Industry RankSector Rank
ROA 2.9%
ROE 7.66%
ROCE 5.4%
ROIC 3.46%
ROICexc 57.36%
ROICexgc N/A
OM 3.71%
PM (TTM) 3.93%
GM 36.62%
FCFM N/A
ROA(3y)-5.25%
ROA(5y)-9.35%
ROE(3y)-11.8%
ROE(5y)-23.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y27.72%
GM growth 5Y9.12%
F-ScoreN/A
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 1.36
Altman-Z N/A
F-ScoreN/A
WACC5.17%
ROIC/WACC0.67
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8628.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.31%
EPS Next Y35.73%
EPS Next 2Y34.95%
EPS Next 3Y30.65%
EPS Next 5Y31.33%
Revenue 1Y (TTM)13.1%
Revenue growth 3Y11.49%
Revenue growth 5Y20.39%
Sales Q2Q%7.59%
Revenue Next Year9.45%
Revenue Next 2Y9.19%
Revenue Next 3Y10.61%
Revenue Next 5Y9.55%
EBIT growth 1Y183.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year349.25%
EBIT Next 3Y70.02%
EBIT Next 5Y45.18%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

BILIBILI INC-SPONSORED ADR / BILI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BILIBILI INC-SPONSORED ADR?

ChartMill assigns a fundamental rating of 3 / 10 to BILI.


Can you provide the valuation status for BILIBILI INC-SPONSORED ADR?

ChartMill assigns a valuation rating of 3 / 10 to BILIBILI INC-SPONSORED ADR (BILI). This can be considered as Overvalued.


How profitable is BILIBILI INC-SPONSORED ADR (BILI) stock?

BILIBILI INC-SPONSORED ADR (BILI) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for BILI stock?

The Price/Earnings (PE) ratio for BILIBILI INC-SPONSORED ADR (BILI) is 29.45 and the Price/Book (PB) ratio is 4.62.


How financially healthy is BILIBILI INC-SPONSORED ADR?

The financial health rating of BILIBILI INC-SPONSORED ADR (BILI) is 2 / 10.